NASDAQ · Financial Statements
Cardiol Therapeutics Inc. (CRDL) Financial Statements
$1.23
NASDAQ: CRDL
Market Cap $141.78M
Overview Financials Dividend Cardiol Therapeutics Inc. most recently reported annual revenue of $0, net profit of $-34.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-31.0M $-30.0M $-22.0M $-40.0M $-34.0M Net Profit $-25.0M $-23.0M $-21.0M $-37.0M $-34.0M EPS $-0.73 $-0.49 $-0.44 $-0.51 $-0.39 Op Margin -49092.4% — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $88.0M $46.0M $37.0M $32.0M $24.0M Total Liabilities $12.0M $7.0M $8.0M $7.0M $6.0M Cash $84.0M $44.0M $35.0M $31.0M $21.0M Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-24.0M $-27.0M $-25.0M $-25.0M $-24.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $9.0M $0 $0 $-2.0M $0 Net Cash Flow $70.0M $-24.0M $-25.0M $-4.0M $-9.0M Free Cash Flow $-24.0M $-27.0M $-25.0M $-25.0M $-24.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.16 EV / EBITDA -5.85 FCF Yield -10.30% Quick Ratio 5.55 Interest Coverage 0.00 Return 1Y -13.53% Return 3Y 41.28% Return 5Y -48.20%
Screens featuring this stock